1. Home
  2. CSWC vs ABCL Comparison

CSWC vs ABCL Comparison

Compare CSWC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSWC
  • ABCL
  • Stock Information
  • Founded
  • CSWC 1961
  • ABCL 2012
  • Country
  • CSWC United States
  • ABCL Canada
  • Employees
  • CSWC N/A
  • ABCL N/A
  • Industry
  • CSWC Textiles
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSWC Consumer Discretionary
  • ABCL Health Care
  • Exchange
  • CSWC Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CSWC 1.1B
  • ABCL 1.1B
  • IPO Year
  • CSWC N/A
  • ABCL 2020
  • Fundamental
  • Price
  • CSWC $20.82
  • ABCL $5.62
  • Analyst Decision
  • CSWC Buy
  • ABCL Strong Buy
  • Analyst Count
  • CSWC 5
  • ABCL 5
  • Target Price
  • CSWC $23.50
  • ABCL $8.00
  • AVG Volume (30 Days)
  • CSWC 656.8K
  • ABCL 6.1M
  • Earning Date
  • CSWC 11-03-2025
  • ABCL 11-06-2025
  • Dividend Yield
  • CSWC 12.24%
  • ABCL N/A
  • EPS Growth
  • CSWC N/A
  • ABCL N/A
  • EPS
  • CSWC 1.64
  • ABCL N/A
  • Revenue
  • CSWC $209,032,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • CSWC $14.60
  • ABCL $16.99
  • Revenue Next Year
  • CSWC $10.75
  • ABCL $62.91
  • P/E Ratio
  • CSWC $12.71
  • ABCL N/A
  • Revenue Growth
  • CSWC 10.52
  • ABCL N/A
  • 52 Week Low
  • CSWC $17.46
  • ABCL $1.89
  • 52 Week High
  • CSWC $25.80
  • ABCL $6.52
  • Technical
  • Relative Strength Index (RSI)
  • CSWC 44.82
  • ABCL 53.17
  • Support Level
  • CSWC $20.18
  • ABCL $5.56
  • Resistance Level
  • CSWC $21.00
  • ABCL $5.97
  • Average True Range (ATR)
  • CSWC 0.35
  • ABCL 0.33
  • MACD
  • CSWC 0.12
  • ABCL -0.06
  • Stochastic Oscillator
  • CSWC 86.50
  • ABCL 33.40

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: